Allspring Global Investments’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,941
| Closed | -$53.4K | – | 2308 |
|
|
2023
Q3 | $53.4K | Buy |
1,941
+805
| +71% | +$22.2K | ﹤0.01% | 2235 |
|
|
2023
Q2 | $38.5K | Buy |
1,136
+496
| +78% | +$16.8K | ﹤0.01% | 2343 |
|
|
2023
Q1 | $23K | Buy |
640
+49
| +8% | +$1.76K | ﹤0.01% | 2469 |
|
|
2022
Q4 | $26.3K | Sell |
591
-13
| -2% | -$579 | ﹤0.01% | 2523 |
|
|
2022
Q3 | $16K | Sell |
604
-1,799
| -75% | -$47.7K | ﹤0.01% | 2646 |
|
|
2022
Q2 | $64K | Sell |
2,403
-21,230
| -90% | -$565K | ﹤0.01% | 2183 |
|
|
2022
Q1 | $804K | Buy |
23,633
+334
| +1% | +$11.4K | ﹤0.01% | 2010 |
|
|
2021
Q4 | $900K | Buy |
+23,299
| New | +$900K | ﹤0.01% | 2005 |
|